Mirae Asset Global Etfs Holdings Ltd. Lyell Immunopharma, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 295,647 shares of LYEL stock, worth $2.43 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
295,647
Previous 308,551
4.18%
Holding current value
$2.43 Million
Previous $197,000
19.29%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding LYEL
# of Institutions
117Shares Held
175MCall Options Held
2.9KPut Options Held
6K-
Mwg Management Ltd. Washington, DC20.2MShares$166 Million18.54% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA16MShares$132 Million9.84% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$124 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$124 Million9.84% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$111 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $2.04B
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...